BAM
PFE icon

Broyhill Asset Management’s Pfizer PFE Stock Holding History

Broyhill Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$239K Hold
8,500
– – 0.22% 71
2025
Q4 		$212K Hold
8,500
– – 0.19% 71
2025
Q3 		$217K Hold
8,500
– – 0.19% 75
2025
Q2 		$206K Hold
8,500
– – 0.19% 71
2025
Q1 		$215K Sell
8,500
-200
-2% -$5.23K 0.18% 73
2024
Q4 		$231K Buy
+8,700
New +$236K 0.2% 68

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Broyhill Asset Management's PFE Position: Q1 2026 in Review

Broyhill Asset Management held its Pfizer (PFE) position steady in Q1 2026 at 8,500 shares worth $239K. The position accounts for 0.22% of the portfolio, ranked #71.

Broyhill Asset Management first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Broyhill Asset Management held 8,500 shares of Pfizer worth $239K as of Q1 2026.
  • Broyhill Asset Management left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.22% of Broyhill Asset Management's portfolio in Q1 2026, its #71 holding.
  • Broyhill Asset Management first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Broyhill Asset Management's 13F filing for Q1 2026, filed 6 May 2026.